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ABC, ATP binding cassette 
CYPs, cytochrome P450s 
DHEAS, dehydroepiandrosteronesulfate 
ER, endoplasmic reticulum 
E17βG, estradiol-17β-glucuronide 
E3S, estrone-3-sulfate 
G6P, glucose-6-phosphate 
HPTLC, high performance thin layer chromatography 
MRP2, multidrug resistance associated protein 2 
NE, nuclear envelope 
Ntcp, Na-taurocholate co-transporting polypeptide 
Oatp, organic anion transporting polypeptide 
RER, rough endoplasmic reticulum 
SER, smooth endoplasmic reticulum 
STS, steroidsulfatase 
TC, taurocholate 
UDPGA, Uridine diphosphate glucuronic acid 
UGTs, Uridine diphosphate glucuronosyltransferases 
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Abstract 
Important reactions of drug metabolism, including UGT mediated glucuronidation and 
steroidsulfatase mediated hydrolysis of sulfates, take place in the endoplasmic 
reticulum (ER) of hepatocytes. Consequently, UGT generated glucuronides, like 
estradiol-17β-glucuronide, have to be translocated back into the cytoplasm to reach 
their site of excretion. Also steroidsulfatase substrates, including estrone-3-sulfate, 
have to cross the ER membrane to reach their site of hydrolysis. Based on their 
physicochemical properties such compounds are not favored for passive diffusion 
and therefore likely necessitate transport system(s) to cross the ER membrane in 
either direction.  
The current study aims to investigate the transport of taurocholate, estradiol-17β-
glucuronide, and estrone-3-sulfate in smooth (SER) and rough (RER) endoplasmic 
reticulum membrane vesicles isolated from Wistar and TR- rat liver.  
Time-dependent and bidirectional transport was demonstrated for taurocholate, 
showing higher uptake rates in SER than RER vesicles. For estradiol-17β-
glucuronide a fast time-dependent efflux with similar efficiencies from SER and RER 
but no clear protein-mediated uptake was shown, indicating an asymmetric transport 
system for this substrate. Estrone-3-sulfate uptake was time-dependent and higher in 
SER than in RER vesicles. Inhibition of steroidsulfatase mediated estrone-3-sulfate 
hydrolysis decreased estrone-3-sulfate uptake but had no effect on taurocholate or 
estradiol-17β-glucuronide transport.  
Based on inhibition studies and transport characteristics, three different transport 
mechanisms are suggested to be involved in the transport of taurocholate, estrone-3-
sulfate and estradiol-17β-glucuronide across the ER membrane. 
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Keywords: Liver, biotransformation, endoplasmic reticulum, estrone-3-sulfate, 
estradiol-17β-glucuronide, transport
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1. Introduction 
Biotransformation and elimination of endogenous and exogenous compounds is an 
important function of the liver. The hepatic drug elimination process occurs in 
hepatocytes and is classified into four phases including drug uptake (phase 0), phase 
1 and 2 biotransformation and excretion of metabolites (phase 3) [1]. Drug uptake 
and metabolite excretion is accomplished by transport proteins localized at the 
basolateral and canalicular membrane of hepatocytes. The transport systems 
localized to the plasma membrane are complemented by intracellular enzymes 
catalyzing phase 1 and phase 2 reactions, converting poorly water-soluble 
compounds into more water-soluble metabolites to enable their excretion into the bile 
or the sinusoidal blood plasma. Phase 1 reactions are mainly accomplished by 
members of the cytochrome P450 enzyme family (CYPs) preparing compounds for 
subsequent phase 2 conjugation. A major phase 2 pathway represents the 
conjugation with glucuronic acid mediated by the family of the UDP-
glucuronosyltransferases (UGTs) [2]. In humans, CYPs and UGTs are involved in the 
clearance of 90% of drugs which undergo hepatic elimination but also in the 
conjugation of endogenous compounds, including estradiol or bilirubin [3]. 
Furthermore, glucuronidation can represent an alternative detoxification pathway for 
bile acid elimination in cholestasis to protect hepatocytes from the cytotoxic effect of 
bile acids in case of accumulation [4]. Elimination of glucuronides into bile is 
accomplished by the multidrug resistance- associated protein 2 (MRP2), which 
belongs to the ATP binding cassette (ABC) transporter superfamily [5]. The lack of 
functional MRP2 is known to be responsible for deficient glucuronide excretion into 
bile, resulting in glucuronide accumulation and conjugated hyperbilirubinemia, known 
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as Dubin Johnson syndrome in humans [6]. A corresponding animal model are the 
so-called TR- rats [7]. 
Both CYPs [8] as well as UGTs [9] are anchored in the membrane of the 
endoplasmic reticulum (ER). In addition, steroidsulfatase (STS, also known as 
estronesulfatase or arylsulfatase C), which is important for steroid activation, is 
anchored as another metabolizing enzyme in the ER membrane [10-12]. The ER is a 
heterogenous compartment structurally divided into three subcompartments, 
including the nuclear envelope (NE), the smooth (SER) and the rough (RER) 
endoplasmic reticulum [13]. The RER harbours membrane bound ribosomes [14] and 
therefore is involved in protein biosynthesis [15]. By contrast, the CYPs [8] and UGTs 
[16] are localized in the SER. Besides in SER, UGTs have also been detected in 
RER and the NE [16]. Localization of STS has been identified in the ER and the NE 
in rat liver [17], but its distribution between SER and RER is still unclear. Besides the 
shared localization of CYPs, UGTs, and STS in the ER membrane, these phase 1 
and phase 2 enzymes differ in the localization of their catalytic sites with respect to 
the cytoplasm. While the CYPs have their catalytic site in the cytoplasm [18], the 
active sites of UGTs [19] and STS [12] are located in the lumen of the ER. 
Consequently, substrates of STS, like estrone-3-sulfate (E3S) or 
dehydroepiandrosteronesulfate (DHEAS), have to cross the ER membrane to reach 
their site of hydrolysis. Due to their physicochemical properties, these compounds 
are not favored for passive diffusion and very likely necessitate transport system(s) to 
get access to the ER lumen. However, until now, no data are available on the 
characterization of the transport of the STS model substrate estrone-3-sulfate across 
the ER membrane. 
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Accordingly, the co-substrate for UGT mediated glucuronidation, the uridine 
diphosphate glucuronic acid (UDPGA) has to be translocated from its site of 
synthesis in the cytoplasm, to its site of action within the ER lumen. After UGT 
mediated glucuronidation, the resulting products have to be transported from the ER 
lumen back into the cytoplasm. Based on their physicochemical properties neither 
UDPGA nor glucuronides are likely to cross the ER membrane by simple diffusion, 
indicating the involvement of transport system(s) in the translocation of these 
compounds across the ER membrane. Evidence for the existence of such transport 
system(s) is given as UDPGA transport has been reported in rat liver microsomes 
[20]. Transport activity into microsomes isolated from rat liver has also been shown 
for different glucuronides [21-24]. However, only one study investigated transport of 
estradiol-17β-glucuronide in ER enriched liver microsomes but this study did not 
distinguish between SER and RER. Finally, carrier-mediated transport of 
taurocholate (TC) into rat liver microsomes, largely being composed of ER has been 
reported a while ago. [25]. 
Based on the knowledge that STS and UGTs have their catalytic site within 
the ER lumen, the present study investigated and characterized the transport activity 
for the UGT model product estradiol-17β-glucuronide (E17βG) as well as the STS 
model substrate estrone-3-sulfate (E3S) in SER and RER vesicles isolated from rat 
liver. Transport of sulfated and glucuronidated model compounds across SER and 
RER membranes were functionally compared. Furthermore, a potential impact of a 
chronic cytoplasmic accumulation of glucuronides on the activity of these transport 
systems was investigated using ER fractions isolated from wild type and from the TR- 
rats. Finally, taurocholate transport into RER and SER was investigated to test for 
potential common transport pathways with phase 2 products. 
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2. Materials and Methods 
2.1. Materials 
[6,7-3H(N)]-estradiol-17β-glucuronide (E17βG, 41.8 Ci/mmol), [6,7-3H(N)]-estrone-3-
sulfate (E3S, 45.6 Ci/mmol), [3H(G)]-taurocholic acid (TC, 5 Ci/mmol) as well as the 
liquid scintillation fluid Filter Count were purchased from Perkin-Elmer 
(Schwerzenbach, Switzerland). Unlabelled substrates including E3S, E17βG, and TC 
as well as valinomycin, puromycin, and ATP were purchased from Sigma Aldrich 
(Buchs, Switzerland). Compounds used for inhibition studies, including UDP-
glucuronic acid (UDPGA), Stx64, and vanadate were purchased from Sigma Aldrich 
(Buchs Switzerland). Glucose-6-phosphate was purchased from Roche (Basel, 
Switzerland) and bovine serum albumin was purchased from Interchim (Montluçon, 
France). All chemicals used were of the highest purity available. HPTLC plates and 
solvents used for HPTLC analysis were purchased from Merck (Darmstadt, 
Germany). 
 
2.2. Animals 
Wistar rats, obtained from Charles River (Charles River Laboratories, Sulzfeld, 
Germany), Sprague Dawley rats obtained from Harlan (Harlan Laboratories, Horst, 
Netherlands), and TR- rats (180–200g), were held in the animal facilities of the 
University Hospital of Zurich. The animals received humane care in accordance with 
local and federal guidelines. Animal experiments were approved by the local 
government’s animal care committee. 
 
2.3. Membrane vesicle isolation 
2.3.1. Isolation of basolateral and canalicular membrane vesicles from rat liver 
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Basolateral and canalicular membrane vesicles were isolated from Sprague Dawley 
rats as described by Meier and colleagues [26]. After isolation, vesicles were rapidly 
frozen and stored in liquid nitrogen until use and protein content was measured using 
the method of Lowry [27]. 
 
2.3.2. Isolation of smooth (SER) and rough (RER) endoplasmic reticulum vesicles 
from rat liver 
SER and RER vesicles were isolated from livers of overnight fasted male Wistar and 
TR- rats (150-200g) by density gradient centrifugation following procedures as 
described previously (procedure B, [28]). After removal of the livers from the animals 
all steps were performed on ice or in the cold room. After density gradient 
centrifugation the SER fraction, located at the 0.6M and 1.3M sucrose interface, was 
collected by careful aspiration. The pelleted RER was rehomogenized in 0.25M 
sucrose in a glass Teflon homogenizer at full speed. Subsequently, SER and RER 
vesicles were recovered by centrifugation at 120 000g for 45min at 4°C. The 
supernatant was discarded and pelleted SER and RER vesicles were resuspended in 
the desired resuspension buffer using a 25G syringe needle. Vesicles were rapidly 
frozen and stored in liquid nitrogen until use. Protein of SER and RER vesicles was 
determined using bicinchoninic acid (Thermo Scientific, Waltham, Massachusetts) 
and bovine serum albumin as standard.  
 
2.4. Western blotting 
Proteins were separated by SDS-PAGE using 7.5% separating gels followed by 
blotting on nitrocellulose membranes (GE Healthcare, Little Chalfont, United 
Kingdom) with standard procedures. Membrane fractions were probed for Cyp3a2 
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(Enzo Lifesciences CR3320, Lausen, Switzerland; 1:7000 dilution), Sec61α (Thermo 
Scientific PA3-014, Waltham, Massachusetts; dilution 1:7000) or PDI (Thermo 
scientific MA3-019, Waltham, Massachusetts; dilution 1:20 000 or 1: 100 000) by 
either incubation at 4°C overnight (Sec61α) or at room temperature for 2hs (Cyp3a2; 
PDI). Either HRP-conjugated goat anti rabbit IgG (GE Healthcare RPN4301, Little 
Chalfont, United Kingdom; for Sec61α and Cyp3a2; dilution 1:30 000) or sheep anti 
mouse IgG (GE Healthcare NA931VS, Little Chalfont, United Kingdom; dilution 1:3 
000) was used as secondary antibody. All antibodies were diluted in TBS-T (150mM 
NaCl, 10mM Tris/HCl pH 7.6, 0.1% Tween 20) containing 5% milk powder. 
UptiLight™ (Interchim, Montluçon, France) was used as chemiluminescent substrate 
for protein detection. Western blot analyses for Cyp3a2 and Sec61α were performed 
for each SER and RER isolation used in this study. 
Primary antibodies against Oatp1a1 [29], Ntcp [30], and Mrp2 [31] were used 
in 1:1000, 1:5000, and 1:2000 dilutions in 5% milk/ TBS-T, respectively. For stripping 
off antibodies, nitrocellulose membranes were incubated for 30min at room 
temperature in stripping buffer (100mM NaCl, 100mM glycine, pH adjusted to 3.0 
with HCl) followed by three washing steps in TBS-T for 10min. Incubation with 
secondary HRP-conjugated goat anti rabbit IgG (GE Healthcare RPN4301, Little 
Chalfont, United Kingdom) and protein detection with UptiLight™ (Interchim, 
Montluçon, France) was performed as described above. 
 
2.5. Transport studies 
2.5.1. Vesicle uptake studies 
Uptake of radioactive labelled substrates was measured by the rapid filtration method 
[32]. Vesicles were quickly thawed in a 37°C waterbath, diluted to a protein 
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concentration of 3.5mg/ml with the appropriate resuspension buffer and revesiculated 
by 20 time aspiration through a 25G needle with a syringe. 20µl (70µg) of vesicles 
were prewarmed at 37°C for 30sec and uptake was initiated by the addition of 80µl of 
incubation buffer containing the tritiated substrate. After the desired time of 
incubation transport was stopped by the addition of 3ml ice-cold stop solution (50mM 
sucrose, 100mM KCl, 0.1mM Ca(gluconate)2, 5mM MgCl2 and 20mM Hepes/Tris pH 
7.4) and solution was rapidly filtered through a 0.45µm nitrocellulose acetate filter 
(Sartorius, Göttingen, Germany). For TC transport studies, filters were presoaked 
with 3ml of 1mM TC solution. Filters were dissolved in Filter Count (Perkin Elmer, 
Schwerzenbach, Switzerland) and radioactivity was measured by liquid scintillation 
counting in a Betacounter (Perkin Elmer, Schwerzenbach, Switzerland). 
 
2.5.1.1. Transport studies at different membrane potentials 
To test for the role of the membrane potential on transport activities, vesicles were 
pretreated with valinomycin (10µg valinomycin per mg protein), added from a stock 
solution (10mg/ml in DMSO), for 30min at room temperature followed by 30min 
incubation on ice prior to transport studies. Subsequently a membrane potential was 
generated by either an inward or outward directed potassium gradient. To generate 
an inward positive membrane potential, vesicles were resuspended in 250mM 
sucrose, 0.1mM Ca(gluconate)2, 20mM Hepes/Tris, pH 7.4 (Kout>Kin resuspension 
buffer) and substrate containing incubation buffer (Kout>Kin incubation buffer) 
consisted of 50mM sucrose, 100mM Kgluconate, 0.1mM Ca(gluconate)2, 2.5mM 
Mg(gluconate)2, 20mM Hepes/Tris pH 7.4. Contrary, an inside negative membrane 
potential was generated by using 50mM sucrose, 100mM Kgluconate, 0.1mM 
Ca(gluconate)2, 20mM Hepes/Tris pH 7.4 as resuspension buffer (Kout<Kin 
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resuspension buffer) and 250mM sucrose, 0.1mM Ca(gluconate)2, 2.5mM 
Mg(gluconate)2, 20mM Hepes/Tris, pH 7.4 as incubation buffer (Kout<Kin incubation 
buffer). 
 
2.5.1.2. ATP dependent uptake studies 
For ATP dependent uptake studies, vesicles were resuspended in 50mM sucrose, 
100mM KNO3, 20mM Hepes/Tris pH 7.4. The substrate containing incubation buffer 
either consisted of 50mM sucrose, 100mM KNO3, 12.5mM Mg(NO3)2, 10mM 
Hepes/Tris, pH 7.4 alone or with 6.25mM ATP. Uptake was performed as described 
in 2.5.1. 
 
2.5.1.3. Detaching of ribosomes from RER vesicles 
Attached ribosomes of RER vesicles were removed using puromycin and high KCl 
concentration as described previously [33]. SER vesicles were treated in parallel as 
control. Briefly, vesicles were treated in Kout>Kin resuspension buffer as described in 
2.5.1.1. or 0.25M sucrose, 0.75M KCl, 1mM puromycin, 50mM Tris/HCl pH 7.4 for 1h 
at room temperature. After centrifugation (15min, 103 856g) SER and ribosome-free 
RER vesicles were resuspended in Kout>Kin resuspension buffer. Protein of SER and 
RER vesicles was determined using bicinchoninic acid (Thermo Scientific, Waltham, 
Massachusetts) and bovine serum albumin as standard and uptake of TC was 
measured at an inward positive membrane potential as described in section 2.5.1 
and 2.5.1.1. 
 
2.5.1.4. Na+-dependent taurocholate uptake  
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For sodium dependent TC transport, vesicles were resuspended in 250mM sucrose, 
0.1mM Ca(gluconate)2, 20mM Hepes/Tris, pH 7.4. The substrate containing 
incubation buffer consisted of 50mM sucrose, 0.1mM Ca(gluconate)2, 2.5mM 
Mg(gluconate)2, 20mM Hepes/Tris pH 7.4 and either 100mM NaCl or KCl. Uptake 
studies were performed as described in section 2.5.1. 
 
2.5.1.5. Osmolarity plots 
Experiments for generating osmolarity plots were performed at an inward positive 
membrane potential at an incubation time point of 10min (see section 2.5.1.1.) [34].  
Vesicles were resuspended in Kout>Kin resuspension buffer (see 2.5.1.1.) and the 
osmolarity outside of the vesicles was increased by adding increasing sucrose 
concentrations, ranging from 50mM to 800mM, to the Kout>Kin incubation buffer (see 
2.5.1.1.). Uptake was performed as described in section 2.5.1.  
Uptake (pmol/mg protein) was plotted against the reciprocal osmolarity of the 
incubation buffer and linear regression analyses were performed using the GraphPad 
prism software (GraphPad Software Inc., San Diego, USA). The amount of substrate 
binding to vesicles is given at the intercept of the extrapolated linear regression with 
the y-axis (uptake), whereas uptake rates observed at identical intra- and 
extravesicular osmolarities corresponding to 250mM sucrose was taken as 100%.  
 
2.5.2. Vesicle efflux studies 
For efflux studies, 100µg vesicles were preincubated with the given concentration of 
radiolabelled substrate in resuspension buffer in parallel with valinomycin treatment 
(see section 2.5.1.1). Efflux was initiated by a 60- fold dilution with incubation buffer. 
After the desired time of incubation at 37°C, efflux was stopped by the addition of ice-
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cold stop solution and vesicle associated radioactivity was measured as described in 
2.5.1 Membrane potentials during efflux studies were generated as described before 
(section 2.5.1.1).  
 
2.6. High performance thin layer chromatography (HPTLC) analysis  
As described previously [22] 20µl (3.5mg/ml protein) vesicles were preincubated at 
37°C and mixed with 80µl of E3S containing (5µM, 3µCi/ml) incubation solution to 
start the reaction. The mixture was incubated for the desired time period at 37°C at a 
thermoshaker (900rpm) and reaction was stopped by the addition of 100µl ice cold 
ethanol. The samples were centrifuged at 20 200g (14 000rpm) for 10min at 4°C and 
25µl of the supernatant were loaded on HPTLC Silicagel 60 plates (Merck, 
Darmstadt, Germany) using an automated TLC sampler (Camag, ATS4, Muttenz, 
Switzerland). Chromatography was performed using a solvent mixture of ethyl 
acetate:methanol:25% ammoniumhydroxide solution at a volume ratio of 37.5:12.5:1. 
The developing chamber was saturated with the same solvent mixture from 10min 
prior to development of the HPTLC plate. The HPTLC plate was developed until the 
solvent front reached 8cm from the bottom of the plate (~15min). The plate was dried 
at 100°C for 10min and a X-ray film (Fujifilm, Dielsdorf, Switzerland) was exposed for 
9 days to 1 month. 
 
2.7. Statistical analysis 
Data are given as means ± SD. The number of independent experiments is given in 
the figure and table legends. 
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Statistical significance was calculated using unpaired t-test and the GraphPad prism 
software (GraphPad Software Inc., San Diego, USA). A p-value <0.05 was 
considered as statistical significant. 
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3. Results 
3.1. Characterization of SER and RER vesicles. 
To test for successful separation of SER and RER, expression of proteins known to 
be present in different ER compartments (Cyp3a2, Sec61α and the proteindisulfid 
isomerase PDI), was analyzed by Western blotting.  
While PDI is reported to be equally distributed between SER and RER [35], 
Sec61α is enriched in the RER [35] and Cyp3a2 in the SER [8]. These markers were 
routinely assessed in the isolated SER and RER fractions. In our ER subfractions, 
PDI showed, as published, similar expression levels in SER and RER and was 
therefore chosen as loading control (Figure 1). Sec61α expression was indeed 
restricted to the RER fractions and Cyp3a2 expression was detected at considerably 
higher levels in SER as compared to the RER fractions but did not reach statistical 
significance in densitometric measurements (Table 1). Hence, we successfully 
isolated membrane fractions enriched in RER or in SER. Interestingly, TR- rats 
showed decreased Cyp3a2 expression compared to Wistar rats, which is in 
accordance to previous data [36], while Sec61α was expressed at similar levels in 
both rat strains (Figure 1, Table 1). 
To assess potential cross-contamination of isolated vesicles with plasma 
membranes, protein expression of basolateral and canalicular membrane proteins, 
including Ntcp, Oatp1a1 and Mrp2, was also tested by Western blotting. In 
comparison to basolateral or canalicular membrane fractions of Male Sprague 
Dawley rats, used as positive controls, expression of all three proteins was only faint. 
Therefore, contamination of RER and SER fractions with plasma membrane is only 
marginal (Figure 1). 
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[Figure 1, Table 1] 
 
3.2 Taurocholate transport 
3.2.1. Taurocholate uptake 
Uptake of taurocholate (TC) into SER and RER vesicles was time-dependent and 
electrogenic (Figure 2A and 2B), showing 1.8 to 2.6 higher transport rates at an 
inward positive membrane potential compared to an inward negative membrane 
potential generated by potassium gradients and valinomycin treatment at 30sec of 
incubation (Figure 2B). Hence, the isolated SER and RER vesicles are transport 
competent and display electrogenic TC uptake, as previously demonstrated for rat 
liver microsomes [25]. Additionally, TC uptake showed an overshoot phenomenon, 
with an about 1.2 fold higher uptake at 30sec compared of uptake rates observed 
after 1h in SER and RER isolated from Wistar and TR- rat liver (Figure 2A).  
Comparing TC uptake rates in SER and RER vesicles, TC uptake was about 
1.5 fold higher in SER than in RER vesicles in Wistar rats at an incubation time of 
30sec. Also TR- rats showed a 2.5 fold higher TC uptake at this time point of 
incubation into SER compared to RER vesicles (Figure 2A). As RER vesicles can 
have a higher protein content due to the attached ribosomes than SER vesicles, SER 
and RER vesicles were treated with puromycin and KCl (see section 2.5.1.3.) to strip 
off attached ribosomes. Even after removal of ribosomes from RER vesicles, uptake 
of TC into SER vesicles was 2.7 fold higher than into RER vesicles (data not shown).  
To exclude that the observed TC transport is due to contamination by 
basolateral membranes, sodium-dependent Ntcp-mediated TC uptake was measured 
(Figure 2C). Basolateral membrane vesicles, which were used as positive control for 
Ntcp-mediated sodium-dependent TC transport, showed only 35% sodium 
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independent of total TC transport. Contrary, 67-83% of total TC transport was sodium 
independent in SER and RER vesicles isolated from Wistar and TR- rat livers. 
Consequently, only a marginal sodium-dependent (Ntcp-mediated) transport activity 
for TC was shown in SER and RER fractions compared to basolateral membrane 
fractions, supporting minimal expression of these proteins observed by Western 
blotting (Figure 1) and consequently attributing the electrogenic TC transport activity 
to SER and RER.  
Comparing vesicles isolated from Wistar and TR- rats, both rat strains showed 
comparable uptake characteristics for TC (Figure 2). 
 
[Figure 2] 
 
3.2.2. Taurocholate efflux 
As found for TC uptake, efflux of this compound out of SER and RER vesicles 
isolated from Wistar and TR- rat liver was also time-dependent, indicating 
bidirectional transport of TC across the ER membrane (Figure 2D). Within 30sec of 
incubation about 70-80% of TC was transported out of SER and RER vesicles. 
Again, differences in TC efflux between Wistar and TR- rats were only minimal. 
 
3.2.3. Taurocholate transport versus binding 
To discriminate between intravesicular uptake and unspecific binding of the substrate 
to the vesicle membrane, osmolarity plots were performed. As shown in figure 3A, 
osmolarity plot for TC demonstrated a slope significantly different from zero. 
Consequently, active transport for TC can be assumed. However, 53% vesicle 
associated TC accounted for binding to membranes.  
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[Figure 3] 
 
3.3. Estradiol-17β-glucuronide transport 
3.3.1. Estradiol-17β-glucuronide uptake and efflux 
For E17βG a fast initial uptake within the first 10sec of incubation was found (Figure 
4A). No change in uptake rates with increasing incubation time was seen between 
10sec and 1min. Nevertheless, at equilibrium (after 1h), E17βG uptake was 1.6 to 1.9 
fold higher as compared to the uptake rates observed at an incubation time of 10sec 
(Figure 4A). The presence of ATP did not affect E17βG uptake rates (Table 2), 
indicating the absence of a functional Mrp in this membrane preparation and 
confirming data of Western blot analysis (Figure 1).  
 
[Figure 4] 
[Table 2] 
 
3.3.2. Estradiol-17β-glucuronide efflux 
A fast efflux of E17βG could be detected in both microsomal fractions of W istar and 
TR- rat livers (Figure 4B), showing export of 42-47% of E17βG already after 5sec of 
incubation. Efflux of E17βG increased with time and after 30sec 66-73% of preloaded 
E17βG were released. At 1h of incubation only 16-20% of the substrates were left in 
the vesicles. Similar efflux rates were observed in SER and RER. Wistar and TR- rats 
showed comparable characteristics of E17βG efflux.  
 
3.3.3. Estradiol-17β-glucuronide transport versus binding 
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Osmolarity plots for E17βG were performed to discriminate between intravesicular 
uptake and unspecific binding. A slope significantly different from zero was shown 
(Figure 3B), demonstrating active transport for E17βG. However, 58% of vesicle 
associated E17βG account for membrane binding.  
 
3.4. Estrone-3-sulfate transport 
3.4.1. Estrone-3-sulfate uptake 
The transport of estrone-3-sulfate (E3S) in SER and RER vesicles isolated from 
Wistar and TR- rat liver was time-dependent. A fast increase of E3S uptake was 
detected within the first 2min of incubation in SER and RER vesicles, (Figure 5A) 
remaining nearly constant between 5 and 10min of incubation. At equilibrium after 1h 
of incubation E3S uptake rates slightly decreased to 82-89% of levels observed at 
10min of incubation (Figure 5A). Higher E3S uptake rates were detected at an inward 
positive membrane potential compared to an inward negative membrane potential, 
showing a 2.5- and 1.9 fold increase in SER membrane vesicles isolated from Wistar 
and TR- rat livers, respectively after 10sec of incubation (Figure 5B). Consequently, 
an inwardly directed positive membrane potential was chosen for further transport 
experiments.  
As observed for TC, E3S showed higher uptake rates in SER compared to 
RER membrane fractions. In Wistar rats, E3S uptake was 6.8 fold higher in SER than 
in RER at 15sec of incubation (Figure 5A). Likewise, in SER isolated from TR- rats a 
2.5 fold increase of E3S uptake compared to the RER fraction was observed (Figure 
5A). 
Similar to TC transport, Wistar and TR- rats showed comparable transport 
characteristics for E3S. 
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[Figure 5] 
 
3.4.2. Estrone-3-sulfate transport versus binding 
In contrast to TC and E17βG, E3S osmolarity plots showed no transport into an 
osmotically active space, suggesting binding of the substrate to or partioning into the 
vesicle membranes (Figure 5C). 
 
3.4.3. Role of steroidsulfatase in estrone-3-sulfate transport 
As E3S uptake into SER and RER vesicles was time-dependent, but showed 100% 
binding to vesicle membranes, high performance thin layer chromatography (HPTLC) 
analyses were performed to investigate the chemical intactness of the substrate at 
the end of the uptake studies.  
HPTLC analysis showed time-dependent E3S hydrolysis in SER (Figure 6A) 
as well as in RER (Figure 6C) vesicles. At 15sec of incubation 92% and 94% of the 
substrate was still intact in RER and SER vesicles, respectively. Only 18% and 42% 
of E3S was not hydrolyzed after 2min in SER and RER vesicles, respectively, 
indicating slightly slower E3S hydrolysis in RER as compared to SER. Complete 
degradation in both ER fractions was observed after 10min. Hence, the binding of the 
estrone, which carries the radioactive label may indeed be partitioning into the 
membrane of the vesicles used for the transport studies. As the catalytic site of 
steroidsulfatase (STS) is located within the ER lumen, vesicles were preincubated 
with the irreversible STS inhibitor Stx64 for 30min at room temperature followed by 
30min incubation on ice prior to HPTLC analyses. Indeed, E3S was prevented from 
hydrolysis at any time point of incubation in SER and RER (Figure 6B and D).  
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The effect of STS inhibition on E3S uptake was therefore also studied in SER 
and RER vesicles either pretreated or not pretreated with Stx64. Similar to the time-
dependent hydrolysis, E3S uptake decreased with time in Stx64 treated vesicles 
(Figure 6E) reaching a maximal inhibitory effect after 5min of incubation. 
 
[Figure 6] 
 
3.5. Inhibition studies 
To compare functional characteristics of TC, E3S and E17βG transport in more 
detail, inhibition studies were performed. Furthermore, a possible involvement of 
already identified ER transporters, including the glucose-6-phosphate transporter [37-
39] and the UDPGA transporter [40-42], in TC, E3S, and E17βG transport was 
investigated. Therefore, UDPGA and glucose-6-phosphate (G6P) were included in 
inhibition experiments. In case of inhibition studies with G6P, vanadate treatment of 
vesicles was included to inhibit the glucose-6-phosphatase [43]. A control experiment 
without vanadate treated vesicles was also performed. 
 
3.5.1. Cis- inhibition studies on TC transport 
As shown in Table 3, TC transport was inhibited by both estrogens, E3S and E17βG, 
at an incubation time of 30sec. E17βG significantly decreased TC uptake in SER and 
RER vesicles to 53% and 71% of the control respectively. E3S also showed a 
significant inhibitory effect on the uptake of TC, reducing uptake rates to 60% of the 
control in SER vesicles. Although TC transport was also reduced to 71% of the 
control in RER vesicles, inhibition did not reach statistical significance. 
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As Stx64 was shown to inhibit E3S uptake, its effect on TC uptake was also 
studied, but no effect could be observed. Likewise, neither UDPGA nor G6P (with or 
without vanadate treatment) affected TC uptake in SER and RER vesicles.  
 
[Table 3] 
 
3.5.2. Cis- inhibition studies on E3S transport 
Table 4 shows the results of inhibition studies for E3S uptake at an incubation time of 
15sec. E3S uptake was significantly inhibited by E17βG in SER, showing a decrease 
to 73% of the control. Although the E3S uptake into RER was reduced to 62% in 
presence of E17βG, this inhibitory effect was not statistically significant. TC did not 
affect E3S uptake, neither in SER nor in RER fractions.  
E3S uptake was also significantly inhibited in vanadate treated vesicles to 54-
57% of control in SER. In RER the inhibitory effect was even more pronounced and 
E3S uptake was almost completely inhibited. The irreversible STS inhibitor Stx64 
decreased E3S transport to 80% and 76% in SER and RER fractions respectively, 
but did not reach statistical significance. No inhibitory effect was observed for 
UDPGA and G6P.  
 
[Table 4] 
 
3.5.3. Trans- inhibition studies on E17βG efflux 
For E17βG efflux, trans-inhibition studies were performed at an incubation time of 
5sec. As shown in Table 5, E3S significantly inhibited E17βG efflux out of SER and 
RER vesicles. Compared to controls, E17βG efflux was inhibited by 59% in SER. In 
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RER the inhibitory effect reduced E17βG efflux to 66% compared to the control, 
which did not reach statistical significance. 
Neither TC, nor one of the other tested compounds, including UDPGA, Stx64 
or G6P (with or without vanadate) affected E17βG efflux.  
 
[Table 5] 
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4. Discussion 
The extensive network of the ER accounts for more than 50% of the total membrane 
surface and about 15% of the total volume in hepatocytes [44] and residents 
enzymes involved in biotransformation reactions, including UGTs [16] and the STS 
[10-12]. As both enzymes [12, 19] have their catalytic sites within the ER lumen, their 
substrates, co-substrates as well as end products have to cross the ER membrane. 
Based on their physicochemical properties these compounds are not favored for 
passive diffusion and necessitate transport systems.  
Therefore we investigated the transport of the STS model substrate E3S and 
the typical UGT generated E17βG across the membrane of the smooth (SER) and 
the rough (RER) ER subcompartment isolated from rat liver. Successful separation of 
SER and RER vesicles isolated as well as only marginal contamination of SER and 
RER with plasma membrane was shown by Western blot analysis. Electrogenic TC 
uptake, shown in the present study, is in accordance to previous data [25] and 
therefore confirms the functionality of the vesicles used in our study. In addition, we 
demonstrated bidirectional TC transport across SER and RER, with higher uptake 
rates in SER compared to RER. For E17βG, a fast efflux out of SER and RER 
vesicles was shown, while no clear protein-mediated uptake was observed for this 
compound. Contrary, E3S uptake increased with time in SER and RER vesicles. 
Likewise similar time-dependency was observed in STS mediated E3S hydrolysis. 
For all three studied substrates, uptake characteristics only minimally differ between 
wild-type and the mutant TR- rats, which lack of the efflux pump Mrp2.  
Electrogenic TC uptake with higher uptake rates at an intravesicular positive 
K+ diffusion potential has previously been reported in total microsomes, in ER 
enriched microsomes [25] as well as in SER vesicles [45] isolated from rat liver. 
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Hence, we used in the present study TC transport as a positive control. TC transport 
into SER has been suggested to be accomplished by the microsomal enzyme 
epoxide hydrolase based on experiments with immunoprecipitation and reconstitution 
in proteoliposomes [45]. However, no differences in bile salt uptake into wild type 
BHK-21 cells and rat epoxide hydrolase transfected BHK-21 cells were later found, 
indicating that this enzyme is unlikely responsible for TC transport across the plasma 
membrane [46] and consequently also not into SER. In rodents, TC uptake into 
hepatocytes is mediated by Oatp1a1, Oatp1a4, and Oatp1b2 located at the 
basolateral membrane [47]. Oatp1a1 and Oatp1a4 expressing Xenopus laevis 
oocytes showed bidirectional TC transport [48]. Additionally, TC transport via 
Oatp1a1 was not affected by a K+ diffusion membrane potential in Xenopus laevis 
oocytes [49]. Contrary, our observations showed higher TC transport rates into SER 
and RER vesicles at an inwardly directed K+ gradient. Besides Oatps, the major part 
of TC uptake in hepatocytes is mediated by the Na+- taurocholate co-transporting 
polypeptide (Ntcp) in a sodium-dependent manner [50]. However, in our study 
sodium dependent uptake of TC accounted for only 20-30% of total TC uptake, which 
is much less than in isolated basolateral plasma membrane vesicles [51]. Based on 
TC transport characteristic shown in our study and a lack of significant amounts of 
Oatp1a1 and Ntcp protein in our SER and RER preparations, these TC transporters 
seem not to be involved in TC transport across SER and RER membranes. At 
present, the physiologic role of possible taurocholate transport into the ER is not fully 
understood. While glucuronidation of bile acids has been reported to be mediated by 
UGT1A3 [52], this pathway is under most situation minor in hepatocellular bile salt 
homeostasis [53]. Under prolonged cholestasis, glucuronidation of bile acids may act 
as an alternative biotransformation pathway for ameliorating the cytotoxicity of bile 
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acids [54]. Whether glucuronidated bile salts leave the lumen of the ER by the same 
transport systems as the one described here remains to be elucidated. 
UGT mediated glucuronidation takes place within the ER lumen [19] and 
requires the exit of the reaction products back to the cytoplasm. This transport 
pathway has been investigated for different glucuronides, including 4-
methylumbelliferyl-β-D-glucuronide [24], phenolphthalein-β-D-glucuronide [23], 
naphthol AS-BI glucuronide [23], morphine-3-glucuronide [23, 55] and E17βG [22] 
using total rat liver microsomes. Glucuronide uptake increased with time in these 
studies and in accordance to our observations fast initial uptake rates were observed 
for E17βG [22], 4-methylumbelliferyl-β-D-glucuronide [24], phenolphthalein-β-D-
glucuronide and naphthol AS-BI glucuronide [23]. After the fast initial uptake phase, 
E17βG content was nearly constant over a time period of 20sec to 1min followed by 
a slow increase up to 1h of incubation in our study. Such a biphasic uptake rate could 
be explained by a trans-inhibition of the transported substrate. Published data 
reported that a steady state level is reached after the initial uptake phase and was 
unchanged for at least 40min or 60min for E17βG [22] or phenolphthalein-β-D-
glucuronide [23] respectively. This difference could be due to different isolation 
procedures of the membrane vesicles investigated. As we have shown here for 
E17βG in SER and RER, efflux of phenolphthalein-β-D-glucuronide [23], morphine-3-
glucuronide [55] and E17βG [22] was also fast and time-dependent out of total rat 
liver microsomes. Comparing time-dependent uptake and efflux of different 
glucuronides, morphine-3-glucuronide [23, 55] showed slower uptake and efflux rates 
as compared to 4-methylumbelliferyl-β-D-glucuronide [24], phenolphthalein-β-D-
glucuronide [23] and E17βG [22], indicating the existence of different transport 
systems for the transport of glucuronides of different molecular weight and 
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consequently size across the ER membrane [23]. An effect of molecular weight on 
glucuronide efflux has also been indicated for bilirubin glucuronide and 1-naphthol 
glucuronide in human liver microsomes [56]. To our knowledge the transport 
system(s) responsible for glucuronide transport across the ER membrane has not 
been identified at the molecular level so far. An antiport with the UGT co-substrate 
UDPGA has been postulated, as extravesicular UDPGA stimulated the efflux of p-
nitrophenol- and phenolphthalein-glucuronide out of preloaded rat liver microsomes 
(trans-stimulation) [21]. UGTrel7 (SLC35D1) has been identified as UDPGA 
transporter [40-42] and therefore could be involved in the UDPGA/glucuronide 
antiport process. As we did not observe any effect of UDPGA on E17βG efflux in 
trans-inhibition studies, neither an antiport with UDPGA nor an involvement of the 
UDPGA transporter in E17βG efflux can be suggested from the present study. This is 
also in accordance to previous cis-inhibition studies showing that extravesicular 
UDPGA had no effect on the uptake of E17βG [22]. The clear and fast efflux of 
E17βG out of ER vesicles and the observed slow, biphasic uptake indicate an 
asymmetric transport system for this compound across the ER membrane, which 
preferentially export E17βG out of vesicles. As evidence is given for the existence of 
different transport systems for glucuronides of different molecular weights, substrate 
specificity of such an asymmetric efflux transporter has to be further evaluated. 
After glucuronidation and translocation of formed glucuronides from the ER 
lumen back into the cytoplasm, glucuronides have to be excreted out of hepatocytes. 
At the canalicular membrane, the ATP binding cassette transporter Mrp2 is 
responsible for the ATP dependent export of glucuronides into the bile [5]. Recently, 
Mrp2 expression in the nuclear envelope, another subcompartment of the ER 
besides SER and RER, has been demonstrated by Western blotting in rat liver 
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nuclear envelope fractions [57]. As we did not find an ATP dependent E17βG uptake 
in SER and RER vesicles, which was also previously absent in total liver microsomes 
[22], and Mrp2 expression was absent in our fractions an involvement of Mrp2 in 
E17βG transport across the ER membrane seems unlikely.  
Compared to TC and E17βG, no data are available studying the transport of E3S 
across the ER membrane. Only one study investigated the transport of NaSO4, 
showing a bidirectional time-dependent but unsaturable transport in total microsomal 
vesicles isolated from rat liver [58]. However, E3S hydrolysis accomplished by STS 
within the ER lumen is the first step in estrogen synthesis [59] and hence requires 
E3S translocation from the cytoplasm into the ER lumen. Although STS is known to 
be expressed in placenta, STS activity and expression has also been detected in rat 
and human liver [17, 60, 61]. E3S is a known substrate of Oatps [47], which are 
therefore possible candidates for E3S transport across the ER membrane. However, 
only low expression of the basolateral rOatp1a1 was found in SER and RER vesicles 
used in our study, indicating that Oatps are not likely to be involved in E3S transport 
across in SER and RER vesicles. Based on its structure, STS itself has been 
discussed to be involved in E3S transport into the ER lumen. Two hydrophobic α-
helices anchor the STS in the ER membrane and are postulated to form a tunnel 
which may allow the substrate to pass the ER membrane and get access to the 
catalytic site of the enzyme [12]. This suggestion is supported by our observations 
showing similarities in the time-dependency of E3S uptake and E3S hydrolysis. We 
demonstrated that in both, SER and RER fractions, E3S is hydrolyzed with time 
reaching complete E3S hydrolysis after 10min. Furthermore, we demonstrated 
inhibition of E3S uptake in SER and RER vesicles by Stx64 and vanadate, which are 
both described to inhibit STS activity [62, 63]. Indeed, we confirmed inhibition of STS 
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mediated E3S hydrolysis by Stx64 using high performance thin layer 
chromatography. These results however do not completely rule out a tight functional 
coupling between STS and a yet unknown E3S transport system. An alternative 
explanation for the observed decrease in E3S hydrolysis in the presence of Stx64 
could also be the reduced uptake of E3S due to presence of this STS inhibitor. Our 
current data do not allow to favor either of these possibilities. 
In conclusion, our study showed clear differences in the transport characteristics of 
TC, E3S, and E17βG across SER and RER membrane vesicles. Furthermore, the 
two STS inhibitors Stx64 and vanadate caused inhibition of E3S uptake but did not 
affect TC uptake or E17βG efflux. Therefore, we conclude that three different 
transport systems (as illustrated in Figure 7) are likely involved in the transport of 
these compounds across the ER membrane. Our data also indicate that neither the 
known ER transporters UGTrel7 [40-42] and G6PT1 [37-39] nor the hepatocellular 
transporters Ntcp, Oatp1a1 and Mrp2 seem to be involved in the translocation of TC, 
E3S, and E17βG across the ER membrane. Based on our Western blot data, we 
conclude that the latter transporters are only found at minimal levels and are 
therefore unlikely relevant for metabolite transport processes in the ER.  
 
[Figure 7] 
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7. Figure legends 
Figure 1: Western blot analysis of Cyp3a2, Sec61α, Oatp1a1, Ntcp, Mrp2, and 
PDI in SER and RER isolated from Wistar and TR- rat livers.  
5µg (Cyp3a2, Mrp2), 50µg (Sec61α) or 100µg (Oatp1a1, Ntcp) protein was loaded 
per lane and separated by SDS-PAGE as given in section 2.4. Samples were probed 
against Cyp3a2, Sec61α, Oatp1a1, Ntcp, Mrp2, and PDI as described in 2.4. PDI 
was used as loading control in SER and RER fractions. Basolateral membrane 
fraction (BLM) isolated from Sprague Dawley rat liver was used as positive control for 
Oatp1a1 and Ntcp expression. Canalicular (CM) membrane fraction isolated from 
Sprague Dawley rat liver was used as positive control for Mrp2 expression. The 
figure shows a representative Western blot of at least two independent SER and 
RER isolations.  
 
Figure 2: TC uptake (A, B, C) and efflux (D) in SER and RER of Wistar and TR- 
rat liver  
A: Uptake of 1µM TC was determined in SER and RER fractions after different time 
points of incubation at 37°C at an inward positive membrane potential as described in 
section 2.5.1. Data are shown for a representative sample of 3 independent 
experiments where uptake is calculated as mean pmol/mg protein ± SD from 
measurements at least in triplicates.  
B: Uptake of 1µM TC was determined in SER and RER fractions after 30sec of 
incubation at an inward positive (+) or negative (-) membrane potential as described 
in section 2.5.1.1. Data are shown for a representative sample of 3 independent 
experiments where uptake is calculated as mean pmol/mg protein ± SD from 
measurements at least in triplicates. Statistically significant difference in TC uptake 
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between an inward positive and negative membrane potential are indicated by 
asterisks as followed: ** for p<0.01 and *** for p<0.001. 
C: Uptake of 1µM TC was determined in SER, RER fractions and basolateral 
membrane (BLM) after 30sec of incubation at 37°C in presence and absence of 
sodium as described in section 2.5.1.4. Data are shown for a representative sample 
of 2 independent experiments. Data show TC uptake in absence of sodium given as 
% of uptake measured in presence of sodium. Values are given as means ± SD from 
measurements at least in triplicates. Statistically significant difference in TC uptake 
between ER fractions and basolateral membrane vesicles are indicated by asterisks 
as followed: * for p<0.5 and ** for p<0.01. 
D: Efflux of TC out of SER and RER vesicles preloaded with 1µM TC was measured 
at an inward positive membrane at 30sec of incubation at 37°C as described in 2.5.2. 
Data (mean ± SD from measurements in triplicates) are shown for a representative 
sample of 2 independent experiments. 
 
Figure 3: Osmolarity plot for TC (A) and E17βG (B) in SER of Wistar rat liver.  
Uptake of TC (1µM) or E17βG (5µM) was measured after an incubation time of 
10min at 37°C at an inward positive membrane potential as described in 2.5.1.5. 
Outside osmolarity (Osm) was increased by adding sucrose ranging from 50 to 
800mM. Data (mean ± SD and linear regression analysis) are shown for a 
representative sample of 2 independent experiments.  
 
Figure 4: Time-dependent uptake (A) and efflux (B) of E17βG in SER and RER 
of Wistar and TR- rat liver.  
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A: Uptake of 5µM E17βG was determined in SER and RER fractions after different 
time points of incubation at 37°C at an inward positive membrane potential as 
described in 2.5.1. Data are shown for a representative sample of 3 independent 
experiments where uptake is calculated as mean pmol/mg protein ± SD from 
measurements at least in triplicates. 
B: Effux of E17βG out of E17βG (5µM) preloaded vesicles was measured at an 
inward positive membrane potential after different time points at 37°C as described in 
2.5.2. Data (mean ± SD from measurements in triplicates) are shown for a 
representative sample of 2 independent experiments. 
 
Figure 5: Uptake (A, B) and osmolarity blot (C) of E3S  
A: Time-dependent uptake of 5µM E3S was determined in SER and RER fractions of 
Wistar and TR- rat liver after different time points of incubation at 37°C at an inward 
positive membrane potential as described in 2.5.1. Uptake is calculated as mean 
pmol/mg protein ± SD from measurements at least in triplicates. Data are shown for a 
representative sample of 2 independent experiments. 
B: Uptake of 5µM E3S was determined in SER and RER fractions of Wistar and TR- 
rat liver after 10sec of incubation at an inward positive (+) or negative (-) membrane 
potential as described in section 2.5.1.1. Data are shown for a representative sample 
of 2 independent experiments where uptake is calculated as mean pmol/mg protein ± 
SD from measurements in triplicates. Statistically significant difference in TC uptake 
between an inward positive and negative membrane potential are indicated by 
asterisks as followed: * for p<0.5 and ** for p<0.01. 
C: Uptake of E3S (5µM) was measured in SER of Wistar rat liver after an incubation 
time of 10min at 37°C at an inward positive membrane potential as described in 
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2.5.1.5. Outside osmolarity (Osm) was increased by adding sucrose ranging from 50 
to 800mM. Data (mean ± SD and linear regression analysis) are shown for a 
representative sample of 2 independent experiments. 
 
Figure 6: Autoradiogram (A-D) and time-dependent uptake (E) of E3S in 
presence (B, D, E) and absence (A, C, E) of the STS inhibitor Stx64.  
A-D: Wi SER (A, B) and RER (C, D), either not preincubated (A, C) or preincubated 
with 1µM Stx64 (B, D), were incubated for 0, 15sec, 30sec, 2min, 5min and 10min 
with 5µM E3S and processed as described in section 2.6. After chromatography, X-
ray film was exposed for 1 month. S, incubation buffer containing 5µM E3S as 
standard. 
 
E: Uptake of 5µM E3S was determined in SER and RER fractions either without (light 
grey) or with (dark grey) Stx64 (1µM) preincubation after different time points of 
incubation at 37°C at an inward positive membrane potential as described in 2.5.1. 
Data are shown for a representative sample of 2 independent experiments. Uptake is 
calculated as mean pmol/mg protein ± SD from measurements at least in triplicates.  
 
Figure 7: Schematic overview of postulated transport systems (T1, T2, T3) for 
E17βG, E3S, and TC in ER vesicles.  
Transport and inhibitory effect (┴) of the different compounds are indicated by the 
different colors used. E, estradiol; E17βG, estradiol-17β-glucuronide; E3S, estrone-3-
sulfate; TC, taurocholate; UDPGA, UDP-glucuronic acid; CYPs, cytochrome P450s; 
UGTs, UDP-glucuronosyltransferases, STS, steroidsulfatase. 
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Table 1: Cyp3a2 and Sec61α expression normalized to PDI expression.  
Rat strain  Fraction  
Cyp3a2/PDI 
ratio  
Sec61α/PDI 
ratio 
Wistar 
 SER  1.60  1.99 
 RER  0.86  0 
TR- 
 SER  0.38  2.49 
 RER  0.023  0 
Data shown in the table represent the mean ratio of the areas measured 
by densitometry for Cyp3a2, Sec61α and PDI expression of two 
independent vesicle preparations, including the one shown in Figure 1. 
Revised Table 1
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Table 2: E17βG uptake in absence and presence of ATP in Wistar SER and RER fractions. 
 SER  RER 
Incubation time 
-ATP  + ATP  -ATP  + ATP 
pmol/ 
mg protein  
pmol/ 
mg protein  
% 
of -ATP  
pmol/ 
mg protein  
pmol/ 
mg protein  
% 
of -ATP 
 
15sec 129±7  116±22  90±17  136±9  108±9  80±6 
1min 138±17  159±18  115±13  132±5  135±8  102±6 
5min 181±20  188±13  104±7  173±14  161±14  93±8 
2h 270±20  265±8  98±3  207±11  223±11  108±5 
Data of E17βG uptake in absence and presence of ATP at the given time points of incubation are shown for a 
representative sample of 2 independent experiments using vesicles from different vesicle preparations. Data are 
given as mean pmol/mg protein ± SD from measurements at least in triplicates. 
Revised Table 2
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Table 3: Summary of cis-inhibition studies of TC uptake at an incubation time of 30sec. 
 SER  RER 
Inhibitor 
(conc.) 
Control  + Inhibitor  Control  + Inhibitor 
pmol/ 
mg protein  
pmol/ 
mg protein  
% 
of control  
pmol/ 
mg protein  
pmol/ 
mg protein  
% 
of control 
 
E17βG (100µM) 37±2  20±1***  53±3  18±3  13±2*  71±3 
E3S (100µM) 33±5  20±4*  60±5  17±4  12±3  71±5 
UDPGA (4mM) 38±2  36±5  94±8  17±3  15±3  88±3 
Stx64 (1µM) 38±3  34±5  90±7  18±2  17±4  94±12 
G6P (1mM) 36±3  32±1  90±5  23±5  21±5  88±7 
Vanadate (1mM) 36±3  33±1  93±5  23±5  21±4  92±5 
Vanadate (1mM) 
G6P (1mM) 
36±3  32±2  90±5  23±5  20±4  87±9 
Data of TC uptake in absence (Control) and presence (+ Inhibitors) of the given inhibitors are given as mean pmol/mg 
protein ± SD of at least 3 independent experiments using vesicles from different vesicle preparations. Statistically 
significant difference in uptake rates compared to the control is given in bold. P-values are indicated by asterisks as 
followed: * for p<0.5 and *** for p<0.001. 
Revised Table 3
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Table 4: Summary of cis-inhibition studies of E3S uptake at an incubation time of 15sec. 
 SER  RER 
Inhibitor 
(conc.) 
Control  + Inhibitor  Control  + Inhibitor 
pmol/ 
mg protein  
pmol/ 
mg protein  
% 
of control  
pmol/ 
mg protein  
pmol/ 
mg protein  
% 
of control 
 
E17βG (100µM) 303±52  220±43*  73±7  136±73  90±56  62±10 
TC (50µM) 303±52  261±66  86±12  136±73  113±58  95±41 
UDPGA (4mM) 281±35  284±41  101±6  146±17  156±27  106±6 
Stx64 (1µM) 319±45  253±26  80±6  154±23  120±54  76±26 
G6P (1mM) 259±62  256±69  99±5  94±43  92±33  103±18 
Vanadate (1mM) 259±62  129±29**  54±25  94±43  4±6*  4±4 
Vanadate (1mM) 
G6P (1mM) 
259±62  137±27**  57±26  94±43  11±14*  12±11 
Data of E3S transport in absence (Control) and presence (+ Inhibitors) of the given inhibitors are given as mean 
pmol/mg protein ± SD of at least 3 independent experiments using vesicles from different vesicle preparations. 
Statistically significant difference in uptake rates compared to the control is given in bold. P-values are indicated by 
asterisks as followed: * for p<0.5; and ** for p<0.01. 
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Table 5: Summary of trans-inhibition studies of E17βG efflux at an incubation time of 5sec.  
 SER  RER 
Inhibitor 
(conc.) 
Control  + Inhibitor  Control  + Inhibitor 
pmol/ 
mg protein/5sec  
pmol/ 
mg protein/5sec  
% 
of control  
pmol/ 
mg protein/5sec  
pmol/ 
mg protein/5sec  
% 
of control 
 
E3S (100µM) 22±2  9±5*  41±19  19±4  13±2  66±6 
TC (50µM) 19±2  21±5  108±16  18±3  21±6  115±18 
UDPGA (4mM) 18±1  20±3  111±20  18±4  19±6  103±14 
Stx64 (1µM) 21±1  19±3  91±16  21±5  20±5  96±9 
G6P (1mM) 20±4  20±5  99±11  20±1  21±2  105±3 
Vanadate (1mM) 20±4  24±3  118±11  20±1  20±3  105±14 
Vanadate (1mM) 
G6P (1mM) 
20±4  24±3  118±11  20±1  21±5  104±16 
Data of E17βG efflux in absence (Control) and presence (+ Inhibitors) of the given inhibitors are given as mean pmol/mg protein/5sec 
transported out of the vesicles ± SD of at least 3 independent experiments using vesicles from different vesicle preparations. Statistically 
significant difference in efflux rates compared to the control is given in bold. P-values are indicated by asterisks as followed: * for p<0.5. 
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Postulated transport systems for  
estradiol-17β-glucuronide (blue), estrone-3-sulfate (red), and taurocholate (green)  
in endoplasmic reticulum vesicles.  
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